Lincoln Pharmaceuticals Limited (LINCOLN.NS) NSE

484.05

+5.3(+1.11%)

Updated at January 14 12:04PM

Currency In INR

Valuation

Market Cap11.06B
Enterprise Value10.93B
P/E Ratio12.06
PEG Ratio-1.64
Price/Sales Ratio1.53
Price/Book Ratio1.35
Enterprise/Revenue1.49
Enterprise/EBITDA7.59

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.14

Management Effectiveness

Return On Assets0.09
Return On Equity0.12

Income Statement

Revenue6.23B
Revenue/Share315.7
Gross Profit3.32B
EBITDA1.24B
Net Income823.46M
Diluted EPS41.11

Balance Sheet

Total Cash2.32B
Total Cash/Share115.82
Total Debt668,000
Total Debt/Equity0
Current Ratio4.71
Book Value Per Share357.45

Price History

52-Week Change-37.23
52-Week High815.7
52-Week Low464.4
Moving Average 50 Days500.09
Moving Average 200 Days541.44

Statistics

Average Volume19,276
Shares Outstanding20.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.8
Trailing Annual Dividend Yield0.37
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A